The challenges of peripheral bone density testing: Which patients need additional central density skeletal measurements?

Journal of Clinical Densitometry

Volumn 1, Issue 3, 1998, Pages 211-217

  Miller, Paul D ^a   Bonnick, Sydney L ^b   Johnston Jr , C Conrad ^b   Kleerekoper, Michael ^b   Lindsay, Robert L ^b   Sherwood, Louis M ^b   Siris, Ethel S ^b  

^a University of Colorado Health Sciences Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002014331     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:1:3:211     Document Type: Article

References (40)

1. Rubin SM, Cummings SR. 1992 Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 116:990-995.
2. Huang C, Ross PD, Wasnich RD. 1998 Short-term and long-term fracture prediction by bone mass measurements: A prospective study. J Bone Miner Res 13:107-113.
3. Black DM, Cummings SR, Melton LJ, III. 1992 Appendicular bone mineral and a woman's lifetime risk of hip fracture. J Bone Miner Res 7:639-646.
4. Kanis JA. 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporosis Int 4:368-381.
5. Pouilles JM, Ribot C, Tremollieres F, et al. 1991 Risk factors of vertebral osteoporosis: Results of a study of 2279 women referred to a menopause clinic. Rev Rheum Mal Osteoartic 58:169-177.
6. Slemenda CW, Hui SL, Longcope C, et al. 1990 Predictors of bone mass in peri-menopausal women. Ann Intern Med 112:96-101.
7. Ross PD, Davis JW, Epstein RS, et al. 1991 Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919-923.
8. National Osteoporosis Foundation. 1998 Osteoporosis: review of the evidence for prevention, diagnosis, treatment and cost-effectiveness analysis, status report. Osteoporosis Int 8, in press.
9. Avecilla LS. 1998 Profession certification and site accreditation in bone densitometry. J Clin Densitometry 1:81-89.
10. Genant HK, Engleke K, Furst T, Gluer CC, Gramp S, Harris ST, et al. 1996 Non-invasive assessment of bone mineral and structure: State of the Art. J Bone Miner Res 11:707-730.
11. Hassager C, Christiansen C. 1995 Measurement of bone mineral density. Calcif Tissue Int 57:1-5.
12. Blake GM, Patel R, Fogelman I. 1998 Peripheral or axial bone density measurements? J Clin Densitometry 1:55-65.
13. Miller PD, McClung M. 1996 Prediction of fracture risk I: Bone density. Am J Med Sci 312:257-259.
14. Pouilles JM, Tremollieres R, Ribot C. 1993 Spine and femur densitometry at the menopause: Are both sites necessary in the assessment of the risk of osteoporosis? Calcif Tissue Int 52:344-347.
15. Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD. 1997 Apparent pre-and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: The OFELY cohort. J Bone Miner Res 2:683-690.
16. Nelson DA, Molley R, Kleerekoper M. 1998 Prevalence of osteoporosis in women referred for bone density testing. J Clin Densitometry 1:5-11.
17. Lindsay R. 1998 Risk assessment using bone mineral density determination. Osteoporosis Int 8(S1):28-31.
18. The WHO Study Group. 1994 Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Switzerland, World Health Organization.
19. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, et al. 1995 Proximal femur bone mineral levels of US adults. Osteoporosis Int 5:389-409.
20. Finkelstein JS, Cleary RL, Butler JP, Antonelli R, Mitlak BH, Deraska DJ, et al. 1994 A comparison of lateral versus anterior-posterior spine dual energy X-ray absorptiometry for the diagnosis of osteopenia. J Clin Endocriol Metab 78:724-730.
21. Ahmed AIH, Blake GM, Rymer JM, Fogelman I. 1997 Screening for osteopenia and osteoporosis: Do the accepted normal ranges lead to overdiagnosis? Osteoporosis Int 7:432-438.
22. Faulkner KG, Roberts LA, McClung MR. 1996 Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporosis Int 6:432-436.
23. Ross P, Huang, Davis J, Imose K, Yates J, Vogel J, et al. 1995 Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneus ultrasound. Bone 16:325-332.
24. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, et al. 1990 Appendicular bone density and age predict hip fracture in women. JAMA 263:665-668.
25. Yates AJ, Ross PD, Lydick E, Epstein R. 1995 Radiographic absorptiometry in the diagnosis of osteoporosis. Am J Med 98(S2A):41S-47S.
26. Wasnich R. 1993 Bone mass measurement: Prediction of risk. Am J Med 95(S5);6S-10S.
27. Greenspan SL, Maitland-Ramsey L, Myers E. 1996 Classification of osteoporosis in the elderly is dependent on site-specific analysis. Calcif Tissue Int 58:409-414.
28. Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL. 1992 How many women have osteoporosis? J Bone Miner Res 7:1005-1010.
29. Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C. 1996 Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up study. Bone 19:9-12.
30. Hui SL, Slemenda CW, Johnston CC Jr. 1988 Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804-1809.
31. Kanis JA. 1997 Diagnosis of osteoporosis. Osteoporosis Int 7(S3):S108-S116.
32. Wasnich RD, Ross PD, Vogel JM, Davis JW. 1989 Osteoporosis: Critique and Practicum. Banyan Honolulu.
33. Miller PD, Bonnick SL, Rosen CJ. 1996 Clinical utility of bone mass measurements in adults: Consensus of an international panel. Semin Arthritis Rheumatol 25:361-372.
34. Miller PD, Rosen C, Bonnick S. 1995 Guidelines for the clinical utilization of bone mass measurement in the adult population. Calcif Tissue Int 57:251-252.
35. Ettinger B, Miller P, McClung M. 1996 Use of bone densitometry results for decisions about therapy for osteoporosis. Letter. Ann Intern Med 125:623.
36. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, et al. 1990 Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73-79.
37. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. 1996 Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541.
38. Hosking D, Chilvers C, Christiansen C, Ravn P, Wasnich R, Ross P, et al. 1998 Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 338:485-492.
39. Stock JL, Bell NH, Chesnut CH III, Ensrud KE, Genant HK, Harris ST, et al. 1997 Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women. Am J Med 103:291-297.
40. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. 1996 Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541.